Shorla Oncology are delighted to announce the appointment of two highly experienced non-executive Board members, John Moloney, Chairman of DCC plc, and Tracy Woody, Executive Vice President, Corporate Strategy at Protagonist Therapeutics. The new Board members will support the commercialization of Shorla’s novel oncology products to the US and global markets. Both John and Tracy have led significant commercial and strategic developments over successful careers in the global Food and Pharma sectors and have long experience in US markets.
John and Tracy join an experienced Board of Directors at Shorla, including Sharon Cunningham and Orlaith Ryan, who together founded the company in 2018. Other board members include Chairperson, Tom Brennan, former Co-founder of EirGen Pharma; Alan O’ Connell, Partner at Seroba Life Sciences and Harcharan (Harry) Singh, Founder, President and CEO of Glopec International Inc.
Read more at: